BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 392407)

  • 1. The complement system in pediatric renal disease.
    Arroyave CM
    Paediatrician; 1979; 8(5-6):349-63. PubMed ID: 392407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3 dependent, C5 independent immune complex glomerulopathy in the mouse.
    Sawtell NM; Hartman AL; Weiss MA; Pesce AJ; Michael JG
    Lab Invest; 1988 Mar; 58(3):287-93. PubMed ID: 2964544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement testing in the diagnosis of immune and autoimmune diseases.
    Schur PH
    Am J Clin Pathol; 1977 Nov; 68(5 Suppl):647-59. PubMed ID: 335876
    [No Abstract]   [Full Text] [Related]  

  • 5. The natural history of membranoproliferative glomerulonephritis: its relation to the hypocomplementemia.
    West CD; Ruley EJ; Spitzer RE; Davis NC
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():531-40. PubMed ID: 4620926
    [No Abstract]   [Full Text] [Related]  

  • 6. Complement activation in acute glomerulonephritis in children.
    Levy M; Sich M; Pirotzky E; Habib R
    Int J Pediatr Nephrol; 1985; 6(1):17-24. PubMed ID: 3997368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.
    Corvillo F; Bravo García-Morato M; Nozal P; Garrido S; Tortajada A; Rodríguez de Córdoba S; López-Trascasa M
    Clin Exp Immunol; 2016 Apr; 184(1):118-25. PubMed ID: 26660535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glomerular complement receptor in immunologically mediated renal glomerular injury.
    Gelfand MC; Shin ML; Nagle RB; Green I; Frank MM
    N Engl J Med; 1976 Jul; 295(1):10-4. PubMed ID: 1272284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
    Craddock CF; Richards NP; Powell RJ; Morgan AG
    Q J Med; 1987 Nov; 65(247):895-8. PubMed ID: 3455546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesangial proliferative glomerulonephritis with unusual intramembranous granular dense deposits.
    Mampaso F; Leyva-Cobián F; Martínez-Montero JC; Gonzalo A; Bellas C; Moneo I; Junquera E
    Clin Nephrol; 1983 Feb; 19(2):92-8. PubMed ID: 6188567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical immunology and immunopathology of glomerulonephritis (author's transl)].
    Lanzer G; Syré G
    Wien Klin Wochenschr; 1980 Sep; 92(18):631-8. PubMed ID: 6451083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury.
    Boyce NW; Holdsworth SR
    J Immunol; 1985 Dec; 135(6):3918-21. PubMed ID: 4067309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of complement and its receptor in the elimination of immune complexes.
    Schifferli JA; Ng YC; Peters DK
    N Engl J Med; 1986 Aug; 315(8):488-95. PubMed ID: 2942776
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible involvement of terminal complement complex in active Heymann nephritis.
    de Heer E; Daha MR; Bhakdi S; Bazin H; van Es LA
    Kidney Int; 1985 Feb; 27(2):388-93. PubMed ID: 3886996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dense deposit disease in a child with febrile sore throat.
    Conti G; De Vivo D; Vitale A; Fede C; Santoro D
    Saudi J Kidney Dis Transpl; 2017; 28(4):925-928. PubMed ID: 28748900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement in glomerulonephritis.
    Simpson IJ
    Aust N Z J Med; 1981; 11(Suppl 1):101-3. PubMed ID: 6942797
    [No Abstract]   [Full Text] [Related]  

  • 18. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
    Davis BK; Cavallo T
    Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
    Strife CF; McAdams AJ; West CD
    Clin Nephrol; 1982 Jul; 18(1):9-16. PubMed ID: 6749363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic urticaria and acquired complement deficiency due to a nephritic factor (C3NeF)].
    Borradori L; Rybojad M; Weiss L; Späth P; Puissant A; Morel P
    Schweiz Med Wochenschr; 1990 Aug; 120(34):1236-41. PubMed ID: 2218445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.